BioE
Simplifying the complex

Cord blood processing. Stem cells. Clinical studies. FDA regulations. Like any biomedical company, BioE lives in a world of complexities. The company turned to Haberman to build awareness for its pioneering human cord blood stem cell technologies. Soon after, researchers, health professionals and investors understood exactly why BioE matters.

Brand and product positioning, key message development, business, consumer and trade media relations, Web content development

The BioE system separates stem cells from cord blood.
It's the only processing system of its kind cleared by FDA.